Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.

dc.contributor.author	Mel Lorenzo, José Ramón
dc.date.accessioned	2017-06-07T07:28:18Z
dc.date.available	2017-06-07T07:28:18Z
dc.date.issued	2011
dc.identifier.issn	1465-5411
dc.identifier.uri	http://hdl.handle.net/20.500.11940/6851
dc.language.iso	eng
dc.title	Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.
dc.type	Publicación de congreso
dc.authorsophos	Manso L.
dc.authorsophos	Ciruelos E.
dc.authorsophos	Codes M.
dc.authorsophos	De La Haba J.
dc.authorsophos	Galan A.
dc.authorsophos	Baena J.
dc.authorsophos	Jaen A.
dc.authorsophos	Gil M.
dc.authorsophos	Murias A.
dc.authorsophos	Blancas I.
dc.authorsophos	Gonzalez E.
dc.authorsophos	Perez D.
dc.authorsophos	Bayo J.L.
dc.authorsophos	Mel J.
dc.authorsophos	Garcia-Martinez E.
dc.authorsophos	Cubedo R.
dc.authorsophos	Salvador J.
dc.identifier.doi	http://dx.doi.org/10.1186/bcr302...
dc.identifier.sophos	11426
dc.journal.title	BREAST CANCER RESEARCH
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Lugo - Hospital Universitario Lucus Augusti::Oncoloxía médica
dc.page.initial	0
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	13

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.